Literature DB >> 3886233

The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes/macrophages and model membranes.

R P Hebbel, R S Schwartz, N Mohandas.   

Abstract

The sickle RBC has a distinct propensity for abnormal adherence to vascular endothelial cells, monocytes, macrophages and aminophospholipid liposomes. Sickle RBC adherence to endothelium may be due to aberrant electrostatic forces, with a major contribution coming from factors in the RBC's plasma environment. The abnormal translocation of aminophospholipids in sickle RBC membranes has been implicated in their adherence to monocytes and liposomes. Abnormal interactions with macrophages (adherence and erythrophagocytosis) may be due to abnormal amounts of IgG on the sickle RBC surface and/or modification of the RBC membrane by dialdehyde byproducts of lipid peroxidation. However, the RBC membrane is an exceedingly complex structure, and these various abnormalities may well be highly interrelated. On the other hand, it is also possible that different abnormalities may be responsible for different cell-cell interactions. Precise identification of the adhesive factor(s) of the sickle RBC membrane will require additional investigation. Regardless of the mechanism(s) involved, data suggest that propensity for adherence of RBC to endothelial cells may correlate with clinical vaso-occlusive severity, perhaps helping to explain not only heterogeneity among patients but also temporal variability in disease severity for individual patients. Likewise, the abnormal adherence of sickle RBCs to monocytes/macrophages may help explain the attenuated survival of sickle RBCs.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886233

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


  14 in total

1.  Renal vascular resistance in sickle cell painful crisis.

Authors:  Birol Guvenc; Kairgeldy Aikimbaev; Cagatay Unsal; Erol Akgul; A Erol Akgul; Figen Binokay; Ayberk Besena
Journal:  Int J Hematol       Date:  2005-08       Impact factor: 2.490

2.  The sickle cell mouse lung: proinflammatory and primed for allergic inflammation.

Authors:  Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall
Journal:  Transl Res       Date:  2015-03-16       Impact factor: 7.012

3.  Hepatic sequestration in sickle cell anemia.

Authors:  C Gutteridge; A C Newland; J Sequeira
Journal:  Br Med J (Clin Res Ed)       Date:  1985-04-20

4.  Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α3.7 triplication in congolese patients than in worldwide series.

Authors:  Tite Minga Mikobi; Prosper Tshilobo Lukusa; Michel Ntetani Aloni; Aimé Lumaka; Pierre Zalagile Akilimali; Koenraad Devriendt; Gert Matthijs; Jean-Marie Mbuyi Muamba; Valerie Race
Journal:  J Clin Lab Anal       Date:  2017-03-09       Impact factor: 2.352

5.  Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.

Authors:  J D Corbett; D E Golan
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

6.  Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Authors:  R H Wang; G Phillips; M E Medof; C Mold
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

7.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

8.  Nrf2 deficiency in mice attenuates erythropoietic stress-related macrophage hypercellularity.

Authors:  Oluwabukola T Gbotosho; Maria G Kapetanaki; Mark Ross; Samit Ghosh; Frances Weidert; Grant C Bullock; Simon Watkins; Solomon F Ofori-Acquah; Gregory J Kato
Journal:  Exp Hematol       Date:  2020-03-06       Impact factor: 3.084

9.  The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design.

Authors:  Bruce W Thompson; Scott T Miller; Zora R Rogers; Renee C Rees; Russell E Ware; Myron A Waclawiw; Rathi V Iyer; James F Casella; Lori Luchtman-Jones; Sohail Rana; Courtney D Thornburg; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada Sarnaik; Thomas H Howard; Lori Luck; Winfred C Wang
Journal:  Pediatr Blood Cancer       Date:  2010-02       Impact factor: 3.167

10.  Vascular complications of sickle cell disease.

Authors:  Ashar Usmani; Roberto F Machado
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.